Growth Metrics

Protalix BioTherapeutics (PLX) Pension (2010 - 2026)

Protalix BioTherapeutics' quarterly Pension came in at $671000.0 in Q1 2026, up 21.78% year-on-year from $551000.0 in Q1 2025, and up 1.51% quarter-over-quarter from $661000.0 in Q4 2025.

Protalix BioTherapeutics has reported Pension for 17 years, with the latest figure at $671000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Pension rose 21.78% year-over-year to $671000.0; the trailing twelve-month figure through Mar 2026 stood at $671000.0 (up 21.78% YoY), and the FY2025 full-year result was $661000.0, up 18.25% from the prior year.
  • Pension for Q1 2026 stood at $671000.0, up from $661000.0 in the prior quarter.
  • The five-year high for Pension was $2.5 million in Q1 2022, with the low at $551000.0 in Q1 2025.
  • Average Pension over 5 years is $1.1 million, with a median of $714000.0 recorded in 2023.
  • Year-over-year, Pension slumped 56.52% in 2023 and rose 21.78% in 2026.
  • Tracing PLX's Pension over 5 years: stood at $1.6 million in 2022, then plunged by 56.52% to $714000.0 in 2023, then decreased by 21.71% to $559000.0 in 2024, then grew by 18.25% to $661000.0 in 2025, then gained by 1.51% to $671000.0 in 2026.
  • The last three Pension figures came in at $671000.0 (Q1 2026), $661000.0 (Q4 2025), and $631000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 671,000.00
Dec 31, 2025 661,000.00
Sep 30, 2025 631,000.00
Jun 30, 2025 615,000.00
Mar 31, 2025 551,000.00
Dec 31, 2024 559,000.00
Sep 30, 2024 730,000.00
Jun 30, 2024 705,000.00
Mar 31, 2024 712,000.00
Dec 31, 2023 714,000.00
Sep 30, 2023 1.46 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 1.78 Mn
Jun 30, 2022 1.75 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.47 Mn
Sep 30, 2021 2.35 Mn
Jun 30, 2021 2.30 Mn
Mar 31, 2021 2.22 Mn
Dec 31, 2020 2.26 Mn
Sep 30, 2020 2.09 Mn
Jun 30, 2020 2.67 Mn
Mar 31, 2020 2.53 Mn
Dec 31, 2019 2.57 Mn
Sep 30, 2019 2.61 Mn
Jun 30, 2019 2.51 Mn
Mar 31, 2019 2.43 Mn
Dec 31, 2018 2.37 Mn
Sep 30, 2018 2.39 Mn
Jun 30, 2018 2.34 Mn
Mar 31, 2018 2.43 Mn
Dec 31, 2017 2.59 Mn
Sep 30, 2017 2.61 Mn
Jun 30, 2017 2.67 Mn
Mar 31, 2017 2.53 Mn
Dec 31, 2016 2.35 Mn
Sep 30, 2016 2.36 Mn
Jun 30, 2016 2.45 Mn
Mar 31, 2016 2.43 Mn
Dec 31, 2015 2.30 Mn
Dec 31, 2014 2.25 Mn
Mar 31, 2014 2.41 Mn
Dec 31, 2013 2.37 Mn
Sep 30, 2013 2.27 Mn
Jun 30, 2013 2.17 Mn
Mar 31, 2013 2.12 Mn
Dec 31, 2012 2.02 Mn
Sep 30, 2012 1.88 Mn
Jun 30, 2012 1.79 Mn
Mar 31, 2012 1.79 Mn
Dec 31, 2011 1.70 Mn
Sep 30, 2011 1.71 Mn
Jun 30, 2011 1.81 Mn
Dec 31, 2010 1.66 Mn